Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Eltrombopag (25mg) Tablet
Therapeutic Category
Immunology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10x10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Eltrombopag 25 mg Tablet is a thrombopoietin receptor agonist indicated for the treatment of chronic immune thrombocytopenia (ITP) and thrombocytopenia in patients with chronic hepatitis C. It helps stimulate platelet production and reduce the risk of bleeding complications.
The drug works by activating thrombopoietin receptors on bone marrow progenitor cells, leading to increased platelet formation. This targeted mechanism supports safe and controlled elevation of platelet counts under medical supervision.
Clinically, Eltrombopag 25 mg Tablet is prescribed in patients with low platelet counts who are unresponsive to conventional therapies, ensuring better disease management and improved treatment outcomes.
Due to its role in long-term hematological care and specialized treatment protocols, this therapy supports steady demand and repeat prescriptions, helping healthcare businesses expand their specialty medicine portfolio and serve patients requiring advanced platelet management solutions.
Common side effects may include headache, nausea, diarrhea, fatigue, and upper respiratory tract infections. Elevated liver enzymes and thromboembolic events may occur rarely.
Eltrohype 25 Tablet is indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It is also used in thrombocytopenia associated with chronic hepatitis C and severe aplastic anemia as advised by a physician.
Use this medicine strictly under medical supervision. Regular monitoring of platelet count and liver function tests is required during therapy. Do not exceed the prescribed dose. Inform the doctor of any history of liver disease or blood clotting disorders.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
Composition : Faropenem (200mg)
Composition : Faropenem (300mg) Tablet
Composition : Levofloxacin (250mg) Tablet
Composition : Levofloxacin (250mg) + Ornidazole (500mg)
Composition : Levofloxacin (500mg)
Composition : Levofloxacin (750mg)
Composition : Moxifloxacin (400mg)
Composition : Nitrofurantoin (100mg) Tablet
Composition : Norfloxacin (400mg) + Tinidazole (600mg)
Composition : Ofloxacin (200mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Eltrombopag 25mg Tablet is a specialty hematology medicine widely used in platelet disorder management, making it a high-value prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from demand in thrombocytopenia management, low platelet count disorders, chronic immune thrombocytopenic purpura (ITP), and hematology care support. It is commonly prescribed by hematologists and specialty physicians for long-term platelet management therapy.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Eltrombopag 25mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from specialty prescription demand, hospital and clinic supply opportunities, and growing acceptance in hematology care segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hematology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.